{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:39:32Z","timestamp":1795138772682,"version":"4.10.3"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1097\/md.0000000000000207","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T12:43:27Z","timestamp":1416573807000},"page":"333-339","source":"Crossref","is-referenced-by-count":185,"title":["Kidney Diseases Associated With Anti-Vascular Endothelial Growth Factor (VEGF)"],"prefix":"10.1097","volume":"93","author":[{"given":"Hassan","family":"Izzedine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Escudier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Gueutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Baumelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Derosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rastilav","family":"Bahleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Hollebecque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djillali","family":"Sahali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Charles","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210226","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1681\/ASN.2007080926","article-title":"Current views on collapsing glomerulopathy.","volume":"19","author":"Albaqumi","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R2-2-20210226","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1345\/aph.1H635","article-title":"Interstitial nephritis secondary to bevacizumab treatment in metastatic leiomyosarcoma.","volume":"41","author":"Barakat","year":"2007","journal-title":"Ann Pharmacother"},{"key":"R3-2-20210226","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1681\/ASN.V10151","article-title":"The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy.","volume":"10","author":"Barisoni","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R4-2-20210226","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1472-8206.2010.00814.x","article-title":"Angiogenic targets for potential disorders.","volume":"25","author":"Bhadada","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"R5-2-20210226","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ndt\/gfn657","article-title":"Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib.","volume":"24","author":"Bollee","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R6-2-20210226","first-page":"125","article-title":"Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy.","volume":"2","author":"Cohen","year":"1989","journal-title":"Mod Pathol"},{"key":"R7-2-20210226","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: A working proposal.","volume":"43","author":"DAgati","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R8-2-20210226","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1538-7836.2005.01361.x","article-title":"Angiogenesis: update.","volume":"3","author":"Dvorak","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R9-2-20210226","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy.","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"R10-2-20210226","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.semnephrol.2010.09.006","article-title":"Biology of anti-angiogenic therapy induced thrombotic microangiopathy.","volume":"30","author":"Eremina","year":"2010","journal-title":"Semin Nephrol"},{"key":"R11-2-20210226","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.","volume":"111","author":"Eremina","year":"2003","journal-title":"J Clin Invest"},{"key":"R12-2-20210226","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1470-2045(07)70037-2","article-title":"Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma.","volume":"8","author":"Frangie","year":"2007","journal-title":"Lancet Oncol"},{"key":"R13-2-20210226","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/ndt\/gfl711","article-title":"Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia.","volume":"22","author":"Garovic","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R14-2-20210226","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/sj.ki.5002742","article-title":"Collapsing glomerulopathy: Many means to a similar end.","volume":"73","author":"Haas","year":"2008","journal-title":"Kidney Int"},{"key":"R15-2-20210226","first-page":"1481","article-title":"Thrombotic microangiopathy and anti-VEGF agents. Nephrol. Dial.","volume":"22","author":"Izzedine","year":"2007","journal-title":"Transplant"},{"key":"R16-2-20210226","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/ndt\/gfl507","article-title":"Gemcitabine-induced thrombotic microangiopathy: a systematic review.","volume":"21","author":"Izzedine","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R17-2-20210226","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ki.2013.344","article-title":"Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.","volume":"85","author":"Izzedine","year":"2014","journal-title":"Kidney Int"},{"key":"R18-2-20210226","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejca.2009.11.001","article-title":"VEGF signalling inhibition-induced proteinuria: mechanisms, significance and management.","volume":"46","author":"Izzedine","year":"2010","journal-title":"Eur J Cancer"},{"key":"R19-2-20210226","first-page":"1745","article-title":"sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome. Ann.","volume":"18","author":"Kapiteijn","year":"2007","journal-title":"Oncol"},{"key":"R20-2-20210226","first-page":"106","article-title":"Collapsing glomerulopathy-A new pattern of renal injury.","volume":"19","author":"Laurinavicius","year":"2002","journal-title":"Semin Diagn Pathol"},{"key":"R21-2-20210226","first-page":"154","article-title":"Thrombotic microangiopathy associated with sunitinib, a veGF inhibitor, in a patient with factor v Leiden mutation.","volume":"1","author":"Levey","year":"2008","journal-title":"NDT Plus"},{"key":"R22-2-20210226","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"R23-2-20210226","doi-asserted-by":"crossref","first-page":"F1656","DOI":"10.1152\/ajprenal.00275.2009","article-title":"The balance of autocrine VEGF-A and VEGF-C determines podocyte survival.","volume":"297","author":"Muller-Deile","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R24-2-20210226","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/ncpneph0476","article-title":"Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma.","volume":"3","author":"Roncone","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"R25-2-20210226","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2215\/CJN.11751111","article-title":"Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease.","volume":"7","author":"Salvatore","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R26-2-20210226","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1111\/j.1523-1755.2004.00621.x","article-title":"The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.","volume":"65","author":"Schrijvers","year":"2004","journal-title":"Kidney Int"},{"key":"R27-2-20210226","doi-asserted-by":"crossref","first-page":"12605","DOI":"10.1074\/jbc.C300012200","article-title":"Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria.","volume":"278","author":"Sugimoto","year":"2003","journal-title":"J Biol Chem"},{"key":"R28-2-20210226","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1523-1755.2004.00865.x","article-title":"The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.","volume":"66","author":"Szczech","year":"2004","journal-title":"Kidney Int"},{"key":"R29-2-20210226","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ndt\/gft465","article-title":"All anti-vascular endothelial growth factor drugs can induce pre-eclampsia-like syndrome: a RARe study.","volume":"29","author":"Vigneau","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R30-2-20210226","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJM200106283442604","article-title":"Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection.","volume":"344","author":"Winston","year":"2001","journal-title":"N Engl J Med"},{"key":"R31-2-20210226","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1177\/1933719109338630","article-title":"Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsia.","volume":"16","author":"Zhao","year":"2009","journal-title":"Reprod Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T22:55:59Z","timestamp":1650668159000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201411040-00002"}},"subtitle":["An 8-year Observational Study at a Single Center"],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":31,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000207","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}